Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
My American Story
Roads, Travel and Traffic
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Jobs
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
My American Story
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Jobs
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about BMRN
Recent news which mentions BMRN
< Previous
1
2
3
4
5
6
7
8
Next >
Expert Ratings for Biomarin Pharmaceutical
October 13, 2022
Tickers
BMRN
Tags
Analyst Ratings
BZI/AAR
BMRN
From
Benzinga
One Rejected BioMarin's Hemophilia Gene Therapy Goes Under FDA Review
October 13, 2022
Tickers
BMRN
Tags
Briefs
FDA
Health Care
From
Benzinga
BioMarin Lays Off 4% Of Its Workforce To 'Simplify' The Company
October 07, 2022
Tickers
BMRN
Tags
Briefs
Health Care
News
From
Benzinga
Do Back-to-Back Approvals Make This Biotech Stock a Buy Now?
September 22, 2022
Tickers
ABBV
BLUE
BMRN
Tags
BLUE
Recent Press Releases
BMRN
From
Motley Fool
BioMarin Says One Participant Diagnosed With Leukemia In Late-Stage Hemophilia Gene Therapy Trial
September 12, 2022
Tickers
BMRN
Tags
Market News
General
Biotech
From
Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 24, 2022
Tickers
AIMD
ANVS
APLS
BMRN
Tags
SRGA
ANVS
APLS
From
Benzinga
BioMarin Receives European Commission's Conditional Marketing Authorization For Gene Therapy Candidate
August 24, 2022
Tickers
BMRN
Tags
EC Approval
Health Care
BMRN
From
Benzinga
What's Next in Pfizer's M&A Ramp-Up?
August 20, 2022
Tickers
ALNY
BMRN
BMY
PFE
Tags
Recent Press Releases
BMRN
PFE
From
Motley Fool
Hopeful Golden Cross Forms On Biomarin Pharmaceutical's Chart
August 09, 2022
Tickers
BMRN
Tags
Markets
BZI/CROSS
Movers
From
Benzinga
Expert Ratings for Biomarin Pharmaceutical
August 04, 2022
Tickers
BMRN
Tags
Market News
Benzinga
BMRN
From
Benzinga
BioMarin Lifts Annual Guidance On Better Than Expected Q2 Earnings
August 04, 2022
Tickers
BMRN
Tags
Benzinga
Market News
Guidance
From
Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Tickers
ALNY
AMRN
ARQT
BMRN
Tags
News
Earnings
FDA
From
Benzinga
These eight health-care stocks can keep you invested in the market with less worry
August 02, 2022
Tickers
BIIB
BMRN
BMY
MEDP
Tags
BMY
MEDP
BIIB
From
MarketWatch
7 Undervalued Biotech Stocks to Buy Before They Boom
July 25, 2022
Tickers
AFMD
BMRN
CRSP
EXEL
Tags
PFE
MRNA
BMRN
From
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 13, 2022
July 13, 2022
Tickers
ABEV
ALNY
ANET
ATRA
Tags
SAM
RDFN
Benzinga
From
Benzinga
Analyst Ratings for Biomarin Pharmaceutical
July 13, 2022
Tickers
BMRN
Tags
Market News
Benzinga
BMRN
From
Benzinga
The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral
June 22, 2022
Tickers
APLS
ATHA
BMRN
CBIO
Tags
NVS
Contracts
PRTK
From
Benzinga
What 4 Analyst Ratings Have To Say About Biomarin Pharmaceutical
June 13, 2022
Tickers
BMRN
Tags
BZI/AAR
BMRN
Analyst Ratings
From
Benzinga
Is Now the Time to Buy This Risky Stock With Huge Upside Potential?
June 04, 2022
Tickers
BMRN
CPRX
Tags
CPRX
Market News
Recent Press Releases
From
Motley Fool
9 Health Care Stocks With Whale Alerts In Today's Session
May 18, 2022
Tickers
ALGN
BCRX
BMRN
BMY
Tags
BZI/AUOA
ILMN
BMY
From
Benzinga
The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, Conference Presentations And More
May 09, 2022
Tickers
ADMA
ALT
BHC
BMRN
Tags
MREO
NVAX
Mid Cap
From
Benzinga
BioMarin Achieves Record Q1 Sales Driven By Recently Approved Achondroplasia Therapy
April 28, 2022
Tickers
AMGN
BMRN
Tags
Health Care
Benzinga
Market News
From
Benzinga
The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis
April 27, 2022
Tickers
ACHV
ALKS
ALLO
AMGN
Tags
ZNTL
CLBS
AZN
From
Benzinga
Biomarin Pharmaceutical Earnings Preview
April 26, 2022
Tickers
BMRN
Tags
BZI/EP
Earnings
Market News
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022
April 25, 2022
Tickers
A
ABR
AGNC
ALNY
Tags
NTRA
AN
BKU
From
Benzinga
10 Biggest Price Target Changes For Monday
April 25, 2022
Tickers
AMAT
AVY
BMRN
CRL
Tags
OSTK
Pre/Market Outlook
Small Cap
From
Benzinga
The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More
April 24, 2022
Tickers
ABBV
ALKS
ALNY
AMGN
Tags
JNJ
HCM
NKTX
From
Benzinga
A Bearish Sign Appears On Biomarin Pharmaceutical's Chart
April 21, 2022
Tickers
BMRN
Tags
BMRN
Benzinga
Market News
From
Benzinga
7 Potential Biotech Stocks Buyout Targets in 2022
April 21, 2022
Tickers
ALNY
AMGN
AZN
BIIB
Tags
MRTX
NVS
VRTX
From
InvestorPlace
Why BioMarin Pharmaceutical Tumbled on Thursday
February 24, 2022
Tickers
BMRN
Tags
BMRN
Recent Press Releases
Market News
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today